Medicem presented at Polymer Networks and Gels conference
Prague - June 2018
New article presenting results of MEDICEM R&D team published
DILAPAN-S confirmed its superiority over Laminaria. New scientific evidence available.March 2015
DILAPAN-S videos introducing the product newly available.March 2015
New DILAPAN-S videos on YouTube
DILAPAN-S: Results of prospective, multicentre data collection on use of the osmotic dilator Dilapan-S in labor prenductionAugust, 2014
Presented at: 23 rd European Congress of Obstetrics and Gynaecology, May 2014, Glasgow, UK. XXIV. European Congress of Perinatal Medicine, June 104, Florence, Italy. 13rd World Congress in Fetal Medicine, June-July, Nice, France.
The Society of Family Planning recommends DILAPAN-SFebruary, 2014
The Clinical Guidelines (2013–4) published by the Society of Family Planning recommend DILAPAN-S for D&E before 20 weeks’ gestation as one of the best methods of cervical preparation.
A randomized clinical study by the American College of Obstetricians and GynecologistsFebruary, 2014
A randomized clinical study entitled ‘Buccal Misoprostol Compared with Synthetic Osmotic Cervical Dilator before Surgical Abortion’ was carried out by the American College of Obstetricians and Gynecologists (2013) among 125 women.